crisantaspase porton biopharma pd.i.s.inf 10.000e
porton biopharma limited, ireland lee view house 13 south terrace , t12 t0ct co. cork - crisantaspase (l-asparaginase from erwinia chrysanthemi) - pd.i.s.inf (ΚΟΝΙΣ ΓΙΑ ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ/ΔΙΑΛΥΜΑ ΠΡΟΣ ΕΓΧΥΣΗ) - 10.000e - crisantaspase (l-asparaginase from erwinia chrysanthemi) 100.000u - asparaginase
enrylaze
jazz pharmaceuticals ireland limited - crisantaspase - Πρόδρομη κυτταρική λεμφοβλαστική λευχαιμία-λέμφωμα - Αντινεοπλασματικοί παράγοντες - enrylaze is indicated as a component of a multi-agent chemotherapeutic regimen for the treatment of acute lymphoblastic leukaemia (all) and lymphoblastic lymphoma (lbl) in adult and paediatric patients (1 month and older) who developed hypersensitivity or silent inactivation to e. coli-derived asparaginase.